Both in Biotechnology
Editas Medicine vs Zura Bio Limited
Over the past year EDIT returned −12.7% and ZURA returned +9.8%; their daily moves had a correlation of 0.31.
EDIT −12.7% ZURA +9.8%Growth of $1, one year, split-adjusted
| Metric | EDIT | ZURA |
|---|---|---|
| Price | $2.67 | $4.04 |
| Market cap | $410.1M | $389.2M |
| Today | −8.87% | +4.94% |
| 1 month | +6.0% | −2.4% |
| 6 months | −7.9% | −22.5% |
| Year to date | +30.2% | −22.9% |
| 1 year | −12.2% | +6.9% |
| Revenue growth (YoY) | +232.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −153.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | — |
| Net cash | $155.9M | $187.7M |
| Dividend yield | — | — |
| Volatility (60d) | 81.4% | 80.2% |
| Short % of float | 25.7% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).